2-[3-(2,5-Dimethyl-1H-pyrrol-1-yl)thiophen-2-yl]-5-(methanesulfonylmethyl)pyrazolo[1,5-a]pyrimidin-7-ol

Catalog No. :
ACHRCK200
CAS No. :
691872-99-8
Molecular Formula :
C18H18N4O3S2
Molecular Weight :
402.50

IUPAC Name:2-(3-(2,5-dimethyl-1H-pyrrol-1-yl)thiophen-2-yl)-5-((methylsulfonyl)methyl)pyrazolo[1,5-a]pyrimidin-7-ol

2-[3-(2,5-Dimethyl-1H-pyrrol-1-yl)thiophen-2-yl]-5-(methanesulfonylmethyl)pyrazolo[1,5-a]pyrimidin-7-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-[3-(2,5-Dimethyl-1H-pyrrol-1-yl)thiophen-2-yl]-5-(methanesulfonylmethyl)pyrazolo[1,5-a]pyrimidin-7-ol
IUPAC Name2-(3-(2,5-dimethyl-1H-pyrrol-1-yl)thiophen-2-yl)-5-((methylsulfonyl)methyl)pyrazolo[1,5-a]pyrimidin-7-ol
Molecular FormulaC18H18N4O3S2
Molecular Weight402.50
SMILESCC1=CC=C(C)N1C1=C(C2=NN3C(O)=CC(CS(C)(=O)=O)=NC3=C2)SC=C1
InChI KeyUTGKQXQMZCAWEQ-UHFFFAOYSA-N
Synonym2-[3-(2,5-DIMETHYL-1H-PYRROL-1-YL)-2-THIENYL]-5-[(METHYLSULFONYL)METHYL]PYRAZOLO[1,5-A]PYRIMIDIN-7-OL;2-[3-(2,5-dimethyl-1H-pyrrol-1-yl)thiophen-2-yl]-5-(methanesulfonylmethyl)pyrazolo[1,5-a]pyrimidin-7-ol;Pyrazolo[1,5-a]pyrimidin-7-ol, 2-[3-(2,5-dimethyl-1H-pyrrol-1-yl)-2-thienyl]-5-[(methylsulfonyl)methyl]-
CAS No.691872-99-8

Synthetic Route by SureRoute

1. ACHRCK200 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVMJE178 route compound structure diagram
    ACVMJE178110-13-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHRCK200 route product structure diagram
    ACHRCK200691872-99-8
Inquiry

2. ACHRCK200 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHRCK200 route product structure diagram
    ACHRCK200691872-99-8
Inquiry

Comments (0)